.On the heels of an FDA being rejected for its own primary rivalrous Novo Nordisk, Eli Lilly is pull...
.Only a few months after application the first patient in a stage 2 trial for newly detected gliobla...
.Eli Lilly's look for being overweight aim ats has actually led it to the darker genome. The Big Pha...
.Collection Biosciences is proceeding up. The tissue treatment provider has actually added on $325 m...
.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to...
.Aelis Farma's chances of securing a quick, favorable selection on a $100 million alternative remitt...
.ProKidney has actually ceased among a set of period 3 tests for its own tissue therapy for renal ai...
.Vaxcyte introduced what analysts referred to as "sensational" stage 1/2 records for its 31-valent p...
.Recursion has discovered via a very early examination of its own tech-enabled strategy to medicatio...
.Call it a situation of really good chemical make up: Acepodia, a biotech based on Nobel Champion sc...